Screener
10x Genomics, Inc. TXG CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by operating activities | 43,094 | 52,059 |
| Investing activities: | ||
| Business combination | (6,101) | — |
| Purchases of property and equipment | (3,185) | (3,471) |
| Purchases of marketable securities | (49,260) | (49,361) |
| Proceeds from maturities of marketable securities | 50,000 | 50,000 |
| Purchase of equity interest rights | (500) | — |
| Net cash used in investing activities | (9,046) | (2,832) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s capex?
- 10x Genomics, Inc. (TXG) reported capex of $1.59M in Q2 2026.
- How has 10x Genomics, Inc.'s capex changed year-over-year?
- 10x Genomics, Inc.'s capex increased by 0.6% year-over-year, from $1.58M to $1.59M.
- What is the long-term trend for 10x Genomics, Inc.'s capex?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s capex has grown at a -50.8% compound annual growth rate (CAGR), from $101.28M to $5.94M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about 10x Genomics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude